Profile
Markus Eckstein
M.D.
Bio
Dr. Eckstein is a board-certified senior consultant pathologist at the University Hospital Erlangen (FAU Erlangen-Nürnberg) in Germany. His clinical interests are centered around genitourinary pathology, immunopathology and predictive molecular pathology. Dr. Eckstein leads a translational research group focusing on systems immunology in cancer and deciphering the targetable surface proteome for future drug development of antigen-specific drug conjugates. He has authored over 200 papers developing an understanding how urothelial cancer cell plasticity shapes the spatial tumor immune microenvironment and influences patient survival and responses to chemotherapy, immunotherapy and antigen-specific drug conjugates. Dr. Eckstein is a fellow of the German Society of Pathology, the International Academy of Pathology and the European Association of Urology (EAU), where he also serves as a board member of the EAU section of uropathology and the EAU section of urological research.
Dr. Eckstein completed his M.D. training, fellowship and residency in surgical and molecular pathology at FAU Erlangen-Nürnberg and University Hospital Erlangen.